PDCD1LG2 and cancer: Furthermore, PIEZO1 showed positive relationships with multiple immune checkpoints, including CD274, CTLA4, HAVCR2, LAG3, PDCD1, PDCD1LG2, SIGLEC15, and TIGIT in pan-cancer (Figure 8B).